High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

There is an urgent need to develop approaches for repairing the damaged heart, discovering new therapeutic drugs that do not have toxic effects on the heart, and improving strategies to accurately model heart disease. The potential of exploiting human induced pluripotent stem cell (hiPSC) technology to generate cardiac muscle “in a dish” for these applications continues to generate high enthusiasm. In recent years, the ability to efficiently generate cardiomyogenic cells from human pluripotent stem cells (hPSCs) has greatly improved, offering us new opportunities to model very early stages of human cardiac development not otherwise accessible. In contrast to many previous methods, the cardiomyocyte differentiation protocol described here does not require cell aggregation or the addition of Activin A or BMP4 and robustly generates cultures of cells that are highly positive for cardiac troponin I and T (TNNI3, TNNT2), iroquois-class homeodomain protein IRX-4 (IRX4), myosin regulatory light chain 2, ventricular/cardiac muscle isoform (MLC2v) and myosin regulatory light chain 2, atrial isoform (MLC2a) by day 10 across all human embryonic stem cell (hESC) and hiPSC lines tested to date. Cells can be passaged and maintained for more than 90 days in culture. The strategy is technically simple to implement and cost-effective. Characterization of cardiomyocytes derived from pluripotent cells often includes the analysis of reference markers, both at the mRNA and protein level. For protein analysis, flow cytometry is a powerful analytical tool for assessing quality of cells in culture and determining subpopulation homogeneity. However, technical variation in sample preparation can significantly affect quality of flow cytometry data. Thus, standardization of staining protocols should facilitate comparisons among various differentiation strategies. Accordingly, optimized staining protocols for the analysis of IRX4, MLC2v, MLC2a, TNNI3, and TNNT2 by flow cytometry are described.     

Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323

Arthropod-borne flavivirus infection continues to cause significant morbidity and mortality worldwide. Identification of drug targets and novel antiflaviviral compounds to treat these diseases has become a global health imperative. A previous screen of 235,456 commercially available small molecules identified the 2-thioxothiazolidin-4-one family of compounds as inhibitors of the flaviviral NS5 capping enzyme, a promising target for antiviral drug development. Rational drug design methodologies enabled identification of lead compound BG-323 from this series. We have shown previously that BG-323 potently inhibits NS5 capping enzyme activity, displays antiviral effects in dengue virus replicon assays and inhibits growth of West Nile and yellow fever viruses with low cytotoxicity in vitro. In this study we further characterized BG-323’s antiviral activity in vitro and in vivo. We found that BG-323 was able to reduce replication of WNV (NY99) and Powassan viruses in culture, and we were unable to force resistance into WNV (Kunjin) in long-term culture experiments. We then evaluated the antiviral activity of BG-323 in a murine model. Mice were challenged with WNV NY99 and administered BG-323 or mock by IP inoculation immediately post challenge and twice daily thereafter. Mice were bled and viremia was quantified on day three. No significant differences in viremia were observed between BG-323-treated and control groups and clinical scores indicated both BG-323-treated and control mice developed signs of illness on approximately the same day post challenge. To determine whether differences in in vitro and in vivo efficacy were due to unfavorable pharmacokinetic properties of BG-323, we conducted a pharmacokinetic evaluation of this small molecule. Insights from pharmacokinetic studies indicate that BG-323 is cell permeable, has a low efflux ratio and does not significantly inhibit two common cytochrome P450 (CYP P450) isoforms thus suggesting this molecule may be less likely to cause adverse drug interactions. However, the T_1/2 of BG-323 was suboptimal and the percent of drug bound to plasma binding proteins was high. Future studies with BG-323 will be aimed at increasing the T_1/2 and determining strategies for mitigating the effects of high plasma protein binding, which likely contribute to low in vivo efficacy.     

Differential regulation by ATP versus ADP further links CaMKII aggregation to ischemic conditions

CaMKII, a major mediator of synaptic plasticity, forms extra-synaptic clusters under ischemic conditions. This study further supports self-aggregation of CaMKII holoenzymes as the underlying mechanism. Aggregation in vitro was promoted by mimicking ischemic conditions: low pH (6.8 or less), Ca²⁺ (and calmodulin), and low ATP and/or high ADP concentration. Mutational analysis showed that high ATP prevented aggregation by a mechanism involving T286 auto-phosphorylation, and indicated requirement for nucleotide binding but not auto-phosphorylation also for extra-synaptic clustering within neurons. These results clarify a previously apparent paradox in the nucleotide and phosphorylation requirement of aggregation, and support a mechanism that involves inter-holoenzyme T286-region/T-site interaction.     

Inhomogeneous Encoding of the Visual Field in the Mouse Retina

1. Download high-res image (181KB)
2. Download full-size image

     

Parallel evolution of site‐specific changes in divergent caribou lineages

The parallel evolution of phenotypes or traits within or between species provides important insight into the basic mechanisms of evolution. Genetic and genomic advances have allowed investigations into the genetic underpinnings of parallel evolution and the independent evolution of similar traits in sympatric species. Parallel evolution may best be exemplified among species where multiple genetic lineages, descended from a common ancestor, colonized analogous environmental niches, and converged on a genotypic or phenotypic trait. Modern North American caribou (Rangifer tarandus) originated from three ancestral sources separated during the Last Glacial Maximum (LGM): the Beringian–Eurasian lineage (BEL), the North American lineage (NAL), and the High Arctic lineage (HAL). Historical introgression between the NAL and the BEL has been found throughout Ontario and eastern Manitoba. In this study, we first characterized the functional differentiation in the cytochrome‐b (cytB) gene by identifying nonsynonymous changes. Second, the caribou lineages were used as a direct means to assess site‐specific parallel changes among lineages. There was greater functional diversity within the NAL despite the BEL having greater neutral diversity. The patterns of amino acid substitutions occurring within different lineages supported the parallel evolution of cytB amino acid substitutions suggesting different selective pressures among lineages. This study highlights the independent evolution of identical amino acid substitutions within a wide‐ranging mammal species that have diversified from different ancestral haplogroups and where ecological niches can invoke parallel evolution.     

Modification of the plasmid initiator protein RepC active site during replication

Abstract pT181 is a Staphylococcus aureus rolling circle replicating plasmid whose copy number is controlled by regulating the synthesis and activity of the initiator protein, RepC. The RepC dimer is modified during pT181 replication by the addition of an oligodeoxynucleotide, giving rise to a new form, RepC*. To purify RepC*, RepC was expressed in S. aureus as a fusion protein with a polyhistidine tail. The histidine-tagged RepC retains its initiation and topoisomerase activities in vitro. Histagged RepC/RepC and RepC/RepC* were purified in a two-step procedure. Peptide mapping, mass spectrometric analysis and protein sequencing of purified RepC and RepC* were carried out, and both proteins appeared identical, except that the peptide containing the RepC active site tyrosine used in nicking activity was absent when the purified RepC* sample was analyzed. The absence of the active site in RepC* suggests that this site was modified during replication. The results provide the first direct biochemical evidence that RepC* is a modified form of RepC, and support a model in which RepC replication of pT181 leaves RepC with an oligonucleotide blocking the active site of one of its subunits.     

Composition,Assembly, and Trafficking of a Wheat Xylan Synthase Complex

Xylans play an important role in plant cell wall integrity and have many industrial applications. Characterization of xylan synthase (XS) complexes responsible for the synthesis of these polymers is currently lacking. We recently purified XS activity from etiolated wheat (Triticum aestivum) seedlings. To further characterize this purified activity, we analyzed its protein composition and assembly. Proteomic analysis identified six main proteins: two glycosyltransferases (GTs) TaGT43-4 and TaGT47-13; two putative mutases (TaGT75-3 and TaGT75-4) and two non-GTs; a germin-like protein (TaGLP); and a vernalization related protein (TaVER2). Coexpression of TaGT43-4, TaGT47-13, TaGT75-3, and TaGT75-4 in Pichia pastoris confirmed that these proteins form a complex. Confocal microscopy showed that all these proteins interact in the endoplasmic reticulum (ER) but the complexes accumulate in Golgi, and TaGT43-4 acts as a scaffold protein that holds the other proteins. Furthermore, ER export of the complexes is dependent of the interaction between TaGT43-4 and TaGT47-13. Immunogold electron microscopy data support the conclusion that complex assembly occurs at specific areas of the ER before export to the Golgi. A di-Arg motif and a long sequence motif within the transmembrane domains were found conserved at the NH₂-terminal ends of TaGT43-4 and homologous proteins from diverse taxa. These conserved motifs may control the forward trafficking of the complexes and their accumulation in the Golgi. Our findings indicate that xylan synthesis in grasses may involve a new regulatory mechanism linking complex assembly with forward trafficking and provide new insights that advance our understanding of xylan biosynthesis and regulation in plants.It is believed that Golgi-localized, multiprotein complexes synthesize plant hemicellulosic polysaccharides, including xylans. Such complexes are not well characterized in plants (Zeng et al., 2010; Atmodjo et al., 2011; Chou et al., 2012), which is in sharp contrast with mammalian and yeast cells (Jungmann and Munro, 1998; McCormick et al., 2000; Giraudo et al., 2001). Xylans are the most abundant plant hemicellulosic polysaccharides on Earth and play an important role in the integrity of cell walls, which is a key factor in plant growth. Any mutations affecting xylan backbone biosynthesis seem to result in abnormal growth of plants due mostly to thinning and weakening of secondary xylem walls, described as the irregular xylem (irx) phenotype. Thus, characterizing the xylan synthase complex (XSC) would have an impact on plant improvement, as well as many industrial applications related to food, feed, and biofuel production (Yang and Wyman, 2004; Faik, 2010). Although the Arabidopsis (Arabidopsis thaliana) irx mutants have revealed the involvement of several glycosyltransferase (GT) gene families in xylan biosynthesis (Brown et al., 2007, 2009; Lee et al., 2007, 2010; Wu et al., 2009, 2010), no XSCs have been purified/isolated from Arabidopsis tissues, and we still do not know whether some of the identified Arabidopsis GTs can assemble into functional XSCs. Furthermore, if GTs do assemble into XSCs, we don’t know the mechanisms by which plant cells control their assembly and cellular trafficking. In contrast to dicots, xylan synthase activity was recently immunopurified from etiolated wheat (Triticum aestivum) microsomes (Zeng et al., 2010). This purified wheat XS activity was shown to catalyze three activities, xylan-glucuronosyltransferase (XGlcAT), xylan-xylosyltransferase (XXylT), and xylan-arabinofuranosyltranferase (XAT), which work synergistically to synthesize xylan-type polymers in vitro (Zeng et al., 2008, 2010). This work focuses on describing protein composition, assembly, and trafficking of this purified wheat XS activity.In all eukaryotes, proteins of the secretory pathway (including GTs) are synthesized in the endoplasmic reticulum (ER) and modified as they go through the Golgi cisternae. Most proteins exit the ER from ER export sites (ERESs; Hanton et al., 2009) and use a signal-based sorting mechanism that allows them to be selectively recruited into vesicles coated by coat protein II complexes (Barlowe, 2003; Beck et al., 2008). For many Golgi-resident type II membrane proteins, di-Arg motifs, such as RR, RXR, and RRR located in their cytosolic NH₂-terminal ends, have been shown to be required for their ER export (Giraudo et al., 2003; Czlapinski and Bertozzi, 2006; Schoberer et al., 2009; Tu and Banfield, 2010). Interestingly, di-Arg motifs located ∼40 amino acids from the membrane on the cytosolic side can also be used to retrieve some type II ER-resident proteins from cis-Golgi (Schutze et al., 1994; Hardt et al., 2003; Boulaflous et al., 2009). In contrast to the signal-based sorting mechanism involved in trafficking between the ER and Golgi, the steady-state localization/retention of proteins (including GTs) in the Golgi is thought to occur through vesicular cycling. Cycling is influenced by various mechanisms, including the length and composition of the transmembrane domain (TMD) of type II GTs (Bretscher and Munro, 1993; Colley, 1997; van Vliet et al., 2003; Sousa et al., 2003; Sharpe et al., 2010), and the oligomerization/aggregation of GTs (kin hypothesis), which suggests that formation of homo- or heterooligomers of GTs in the Golgi may prevent their recruitment into clathrin-coated vesicles (Machamer, 1991; Nilsson et al., 1993; Weisz et al., 1993; Cole et al., 1996). Some Golgi-resident GTs are predicted to have a cleavable NH₂-terminal secretion signal peptide (SP) and would therefore exist as soluble proteins in the Golgi lumen. To maintain their proper Golgi localization, these processed GTs are likely part of multiprotein complexes anchored to integral membrane proteins. The fact that homologs of many of the trafficking proteins from mammalian and yeast cells are found in plants indicates that trafficking machineries of the plant secretory pathway are likely conserved (d’Enfert et al., 1992; Bar-Peled and Raikhel, 1997; Batoko et al., 2000; Pimpl et al., 2000; Phillipson et al., 2001; Hawes et al., 2008).It is becoming increasingly evident that understanding the mechanisms controlling protein-protein interaction, sorting, and trafficking of polysaccharide synthases (including XSCs) will help elucidate how plants regulate cell wall synthesis and deposition during their development. To this end, we believe that the purified wheat XS activity (Zeng et al., 2010) is an excellent model for this type of study. In this work, proteomics was used to determine the protein composition of the purified XS activity. Confocal microscopy and immunogold transmission electron microscopy (TEM) were used to investigate the assembly and trafficking of the complex. Our proteomics data showed that the purified activity contains two GTs, TaGT43-4 and TaGT47-13, two putative mutases, TaGT75-3 and TaGT75-4, and two non-GT proteins: a germin-like protein (TaGLP) belonging to cupin superfamily and a protein specific to monocots annotated as wheat vernalization-related protein 2 (TaVER2). Microscopy analyses revealed that all these proteins interact in the ER, but the assembled complexes accumulate in the Golgi. Export of these complexes from the ER is controlled by the interaction between TaGT43-4 and TaGT47-13. Characterization of the wheat XSC and its trafficking furthers our understanding of xylan biosynthesis in grasses and helps elucidate how polysaccharide synthase complexes are assembled, sorted, and maintained in different compartments of the secretory pathway.     

Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-β1 in murine mammary epithelial cells

Cyclin-dependent kinases (cdks) are a family of proteins whose function plays a critical role in cell cycle traverse. Transforming growth factor-β₁ (TGF-β₁) is a potent growth inhibitor of epithelial cells. Since cdks have been suggested as possible biochemical markers for TGF-β growth inhibition, we investigated the effect of TGF-β₁ on cdc2 and cdk2 in a normal mouse mammary epithelial cell line (MME) and a TGF-β-resistant MME cell line (BG18.2). TGF-β₁ decreases newly synthesized cdc2 protein levels within 6 h after addition. Coincident with this decrease in newly synthesized cdc2 protein was a marked reduction in its ability to phosphorylate histone H1. This decrease in kinase activity is not due to a change in steady-state levels of cdc2 protein, since mRNA and total protein levels of cdc2 are not reduced until 12 h after TGF-β₁ addition. This suggests that the kinase activity of cdc2 is dependent on newly synthesized cdc2 protien. Moreover, the protein synthesis of another cyclin-dependent kinase, cdk2, is not effected by TGF-β₁ addition, but its kinase activity is substantially reduced. Thus, it appears that TGF-β decreases the kinase activity of both cdc2 and cdk2 by distinct mechanisms.